RMD
ResMed Inc. (RMD)
Last Price$233.1(0.2%)
Market Cap$34.6B
Last Earnings date
Sep'24
Q3 2024
($2.12)
191.3% miss
$1,282.1M
1.1% beat
Next quarter EPS Estimate
$2.29
21.8%YoY

RMD Earnings and Expectations

Revenue

Crunching data... Almost there!

RMD EPS (Earnings Per Share)

Crunching data... Almost there!

RMD Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$200.0M$400.0M$600.0M$800.0M$1,000.0M$1,200.0M$1,400.0MApr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24Oct'24$769.5M$751.9M$768.8M$904.0M$864.5M$950.3M$1,116.9M$963.0M$1,197.0M$1,224.5M
Value Sense
Actual Revenue
Forecast Revenue

RMD Earnings History

Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$422.5M$453.1M$411.6M$454.5M$453.9M$518.6M$465.5M$530.4M$514.2M$556.7M$523.7M$601.3M$591.6M$623.6M$588.3M$651.1M$662.2M$705.0M$681.1M$736.2M$769.5M$770.3M$751.9M$800.0M$768.8M$876.1M$904.0M$894.9M$864.5M$914.7M$950.3M$1,033.7M$1,116.9M$1,122.1M$963.0M$1,162.8M$1,197.0M$1,223.2M$1,224.5M$1,282.1M
Revenue estimate$429.0M$429.0M$429.0M$429.0M$453.9M$453.9M$453.9M$453.9M$514.2M$514.2M$514.2M$514.2M$546.6M$546.6M$546.6M$546.6M$659.4M$699.1M$659.0M$730.0M$724.1M$752.0M$710.1M$782.6M$797.0M$799.5M$856.6M$921.9M$904.6M$910.6M$949.8M$996.1M$1,050.8M$1,141.6M$1,103.4M$1,150.4M$1,174.2M$1,218.4M$1,185.2M$1,267.6M
Revenue surprise1.5%5.6%4.0%6.0%0.0%14.3%2.5%16.9%0.0%8.3%1.8%16.9%8.2%14.1%7.6%19.1%0.4%0.8%3.3%0.8%6.3%2.4%5.9%2.2%3.5%9.6%5.5%2.9%4.4%0.5%0.1%3.8%6.3%1.7%12.7%1.1%1.9%0.4%3.3%1.1%
EPS actual$0.65$0.62$0.57$0.65$0.63$0.59$0.54$0.54$0.62$0.72$0.61$0.07$0.77$0.77$0.74$0.87$0.74$0.48$0.84$1.11$1.13$1.23$1.23$1.24($0.54)$1.34$1.40$1.38$1.22$1.33$1.44$1.53$1.58$1.56$1.49$1.42$2.04$1.99$2.12($2.12)
EPS estimate$0.67$0.67$0.67$0.67$0.68$0.68$0.68$0.68$0.71$0.71$0.71$0.71$0.78$0.78$0.78$0.78$0.84$0.92$0.87$1.01$1.03$1.10$1.02$1.27$1.29$1.29$1.37$1.50$1.46$1.44$1.54$1.61$1.61$1.68$1.62$1.78$1.93$2.08$2.05$2.32
EPS surprise3.0%7.5%14.9%3.0%7.4%13.2%20.6%20.6%12.7%1.4%14.1%90.1%1.3%1.3%5.1%11.5%11.9%47.6%3.9%10.4%9.2%12.2%21.1%2.7%141.9%3.6%2.0%7.7%16.3%7.8%6.2%5.2%1.6%7.1%8.0%20.1%5.8%4.5%3.2%191.3%

Overview of financial statements

Income statement
Balance sheet
Cash Flow statement
$1,282.1M 10.3% YoY
$751.3M 16.1% YoY
58.6% margin
Cost of revenue
$530.8M 2.9% YoY
Operating income
$417.2M 51.7% YoY
32.5% margin
Other: $1,355.0K
Net interest: $2,436.0K
Operating expenses
$334.0M 8.6% YoY
Pre-tax income
$418.3M 61.2% YoY
32.6% margin
Net income
$344.6M 65.0% YoY
26.9% margin
Income tax
$73.7M
17.6% tax rate
R&D
$81.4M 10.1% YoY
6.3% of revenue
SG&A
$241.6M 8.8% YoY
18.8% of revenue

Competing with RMD Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$34.6B
$4,926.8M
$4.03
10.3%
N/A
Beat by 1.1%
Miss by 191.3%
1.3%
(213.5%)
Beats: 7
Misses: 3
9.2%
35.4%
$207.3B
$8,352.1M
$8.46
25.2%
123.8%
Beat by 7.8%
Beat by 117.1%
(8.7%)
(53.6%)
Beats: 8
Misses: 2
14.2%
20.5%
$66.3B
$20.6B
$6.03
9.8%
8.2%
Beat by 1.2%
Miss by 64.8%
5.5%
228.9%
Beats: 8
Misses: 2
9.0%
145.1%
$46.6B
$9,926.1M
$1.48
0.9%
(100.0%)
Beat by 2.8%
Miss by 100.0%
1.1%
0.0%
Beats: 8
Misses: 2
2.8%
50.8%
$18.6B
$3,895.4M
$1.97
9.8%
34.9%
Beat by 2.1%
Miss by 36.3%
(3.9%)
57.8%
Beats: 6
Misses: 4
5.8%
102.2%
$17.9B
$12.9B
($1.28)
(29.1%)
N/A
undefinedN/A
undefinedN/A
(4.6%)
(150.5%)
Beats: 6
Misses: 4
148.7%
N/A
$16.9B
$2,893.1M
$6.74
2.3%
(3.8%)
Beat by 1.2%
Beat by 3.5%
(2.8%)
(6.1%)
Beats:
Misses:
5.3%
10.7%
$14.7B
$4,038.9M
$3.18
0.9%
(15.5%)
Beat by 4.5%
Miss by 14.1%
1.0%
19.0%
Beats: 8
Misses: 2
3.4%
27.1%
$10.4B
$2,094.4M
($5.68)
9.4%
N/A
Beat by 19.5%
Miss by 879.3%
(16.8%)
(115.8%)
Beats: 9
Misses: 1
1.9%
161.9%
$9,757.8M
$3,582.9M
$5.65
1.1%
60.0%
Miss by 0.7%
Beat by 20.6%
10.6%
(14.1%)
Beats: 9
Misses: 1
5.0%
4.4%

FAQ

1. When was ResMed Inc.'s last earnings date?

ResMed Inc.'s last earnings date was Sep'24 (Q3 2024).

2. What is ResMed Inc.'s EPS, and was there a surprise?

ResMed Inc.'s EPS was ($2.12), with a 191.3% miss.

3. What is ResMed Inc.'s revenue, and was there a surprise?

4. What is ResMed Inc.'s next quarter EPS estimate?

ResMed Inc.'s next quarter EPS estimate is $2.29, with an expected 21.8% YoY growth.